Article Type
Changed
Wed, 03/27/2019 - 13:12
Display Headline
Policy & Practice : Want more health reform news? Subscribe to out podcast – search 'Policy & Practice' in the iTunes store

Election Had Abortion Impact

Republican victories in the House of Representatives gave a solid majority to abortion foes in the coming Congress, according to an analysis by the prolife group the American Center for Law and Justice. The 111th Congress had “183 reliable pro-life representatives,” wrote the center's chief counsel Jordan Sekulow in a blog post. “Next year, there will be no less that 230 solid pro-life representatives, a 47-seat net gain that pushes the pro-life vote over the minimum 218 margin” to pass legislation, he added.

Objects Left After Girls' Surgeries

Girls who undergo gynecologic surgeries have a higher likelihood that a sponge or other foreign body will be left in their bodies than do girls getting other types of surgery, according to researchers at Johns Hopkins University. They scanned nationwide quality data on nearly 2,000,000 operations in children to find 413 foreign-body incidents in children of either sex. The scientists reported in the Archives of Surgery that pediatric gynecologic surgery carried a 4.13 odds ratio of a foreign body being left behind, compared with other surgeries of people under 18 years of age. The study showed that although this led to 8-day longer hospital stays and $35,681 higher total hospital charges than operations in children without foreign bodies left behind, they did not increase mortality.

Mammography Devices Relisted

The FDA is making it easier for companies to get new digital mammography systems approved. The agency said it is reclassifying these devices, known as full field digital mammography systems, as medium-risk (class II) devices. When first approved by the agency in 2000, digital mammography systems were categorized at high-risk (class III) because of their novelty. Since then, digital mammography has been validated in scientific studies involving tens of thousands of patients, the agency said. To win approval for a class III device, companies need to prove safety and effectiveness. Class II approval involves establishing that a device is substantially equivalent to one already on the market. Today, about 70% of the mammography units in use are digital and 70% of certified U.S. mammography centers have at least one digital unit, the FDA said.

Women Get Coverage Money Back

Because of a hotline complaint by one woman denied coverage, an insurance company is paying a total of $148,000 for 984 illegally denied claims for contraception coverage, according to a blog post from the Washington State Office of the Insurance Commissioner. The Seattle Times reported that the claims were for intrauterine device removals and were denied over 8 years by Regence BlueShield. The blog post said that only three women had appealed their denials, which were all upheld. One woman recently called the state office, which then decided that all the denials had violated a 2001 Insurance Commission rule that says, “In Washington, all state regulated health plans that have comprehensive prescription drug coverage must cover prescription contraceptives.” Insurance company officials told the newspaper that they had coded the procedure incorrectly.

FDA Sued for Lack of Action

The Center for Reproductive Rights is suing the Food and Drug Administration for failing to respond to a 2009 court order to make the morning-after pill called Plan B (levonorgestrel) an over-the-counter product for women under 18 as well as for those older. “The FDA has had ample time, countless opportunities, and overwhelming scientific evidence put before it to make a decision on Plan B” for younger women, said Nancy Northup, president of the Center for Reproductive Rights, in a statement. “The president promised that his administration would reverse the Bush policy of politics trumping science. But when it comes to emergency contraception, it's a new administration playing the same old games.” The center said that although the FDA had agreed to follow the 2009 ruling soon after it was made, the agency this year said that it does not intend to reconsider the center's petition that had prompted the original suit.

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Election Had Abortion Impact

Republican victories in the House of Representatives gave a solid majority to abortion foes in the coming Congress, according to an analysis by the prolife group the American Center for Law and Justice. The 111th Congress had “183 reliable pro-life representatives,” wrote the center's chief counsel Jordan Sekulow in a blog post. “Next year, there will be no less that 230 solid pro-life representatives, a 47-seat net gain that pushes the pro-life vote over the minimum 218 margin” to pass legislation, he added.

Objects Left After Girls' Surgeries

Girls who undergo gynecologic surgeries have a higher likelihood that a sponge or other foreign body will be left in their bodies than do girls getting other types of surgery, according to researchers at Johns Hopkins University. They scanned nationwide quality data on nearly 2,000,000 operations in children to find 413 foreign-body incidents in children of either sex. The scientists reported in the Archives of Surgery that pediatric gynecologic surgery carried a 4.13 odds ratio of a foreign body being left behind, compared with other surgeries of people under 18 years of age. The study showed that although this led to 8-day longer hospital stays and $35,681 higher total hospital charges than operations in children without foreign bodies left behind, they did not increase mortality.

Mammography Devices Relisted

The FDA is making it easier for companies to get new digital mammography systems approved. The agency said it is reclassifying these devices, known as full field digital mammography systems, as medium-risk (class II) devices. When first approved by the agency in 2000, digital mammography systems were categorized at high-risk (class III) because of their novelty. Since then, digital mammography has been validated in scientific studies involving tens of thousands of patients, the agency said. To win approval for a class III device, companies need to prove safety and effectiveness. Class II approval involves establishing that a device is substantially equivalent to one already on the market. Today, about 70% of the mammography units in use are digital and 70% of certified U.S. mammography centers have at least one digital unit, the FDA said.

Women Get Coverage Money Back

Because of a hotline complaint by one woman denied coverage, an insurance company is paying a total of $148,000 for 984 illegally denied claims for contraception coverage, according to a blog post from the Washington State Office of the Insurance Commissioner. The Seattle Times reported that the claims were for intrauterine device removals and were denied over 8 years by Regence BlueShield. The blog post said that only three women had appealed their denials, which were all upheld. One woman recently called the state office, which then decided that all the denials had violated a 2001 Insurance Commission rule that says, “In Washington, all state regulated health plans that have comprehensive prescription drug coverage must cover prescription contraceptives.” Insurance company officials told the newspaper that they had coded the procedure incorrectly.

FDA Sued for Lack of Action

The Center for Reproductive Rights is suing the Food and Drug Administration for failing to respond to a 2009 court order to make the morning-after pill called Plan B (levonorgestrel) an over-the-counter product for women under 18 as well as for those older. “The FDA has had ample time, countless opportunities, and overwhelming scientific evidence put before it to make a decision on Plan B” for younger women, said Nancy Northup, president of the Center for Reproductive Rights, in a statement. “The president promised that his administration would reverse the Bush policy of politics trumping science. But when it comes to emergency contraception, it's a new administration playing the same old games.” The center said that although the FDA had agreed to follow the 2009 ruling soon after it was made, the agency this year said that it does not intend to reconsider the center's petition that had prompted the original suit.

Election Had Abortion Impact

Republican victories in the House of Representatives gave a solid majority to abortion foes in the coming Congress, according to an analysis by the prolife group the American Center for Law and Justice. The 111th Congress had “183 reliable pro-life representatives,” wrote the center's chief counsel Jordan Sekulow in a blog post. “Next year, there will be no less that 230 solid pro-life representatives, a 47-seat net gain that pushes the pro-life vote over the minimum 218 margin” to pass legislation, he added.

Objects Left After Girls' Surgeries

Girls who undergo gynecologic surgeries have a higher likelihood that a sponge or other foreign body will be left in their bodies than do girls getting other types of surgery, according to researchers at Johns Hopkins University. They scanned nationwide quality data on nearly 2,000,000 operations in children to find 413 foreign-body incidents in children of either sex. The scientists reported in the Archives of Surgery that pediatric gynecologic surgery carried a 4.13 odds ratio of a foreign body being left behind, compared with other surgeries of people under 18 years of age. The study showed that although this led to 8-day longer hospital stays and $35,681 higher total hospital charges than operations in children without foreign bodies left behind, they did not increase mortality.

Mammography Devices Relisted

The FDA is making it easier for companies to get new digital mammography systems approved. The agency said it is reclassifying these devices, known as full field digital mammography systems, as medium-risk (class II) devices. When first approved by the agency in 2000, digital mammography systems were categorized at high-risk (class III) because of their novelty. Since then, digital mammography has been validated in scientific studies involving tens of thousands of patients, the agency said. To win approval for a class III device, companies need to prove safety and effectiveness. Class II approval involves establishing that a device is substantially equivalent to one already on the market. Today, about 70% of the mammography units in use are digital and 70% of certified U.S. mammography centers have at least one digital unit, the FDA said.

Women Get Coverage Money Back

Because of a hotline complaint by one woman denied coverage, an insurance company is paying a total of $148,000 for 984 illegally denied claims for contraception coverage, according to a blog post from the Washington State Office of the Insurance Commissioner. The Seattle Times reported that the claims were for intrauterine device removals and were denied over 8 years by Regence BlueShield. The blog post said that only three women had appealed their denials, which were all upheld. One woman recently called the state office, which then decided that all the denials had violated a 2001 Insurance Commission rule that says, “In Washington, all state regulated health plans that have comprehensive prescription drug coverage must cover prescription contraceptives.” Insurance company officials told the newspaper that they had coded the procedure incorrectly.

FDA Sued for Lack of Action

The Center for Reproductive Rights is suing the Food and Drug Administration for failing to respond to a 2009 court order to make the morning-after pill called Plan B (levonorgestrel) an over-the-counter product for women under 18 as well as for those older. “The FDA has had ample time, countless opportunities, and overwhelming scientific evidence put before it to make a decision on Plan B” for younger women, said Nancy Northup, president of the Center for Reproductive Rights, in a statement. “The president promised that his administration would reverse the Bush policy of politics trumping science. But when it comes to emergency contraception, it's a new administration playing the same old games.” The center said that although the FDA had agreed to follow the 2009 ruling soon after it was made, the agency this year said that it does not intend to reconsider the center's petition that had prompted the original suit.

Publications
Publications
Topics
Article Type
Display Headline
Policy & Practice : Want more health reform news? Subscribe to out podcast – search 'Policy & Practice' in the iTunes store
Display Headline
Policy & Practice : Want more health reform news? Subscribe to out podcast – search 'Policy & Practice' in the iTunes store
Article Source

PURLs Copyright

Inside the Article

Article PDF Media